Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Telmisartan

An angiotensin II AT1 receptor blocker (sartan) that relaxes blood vessels and lowers blood pressure. Patented in 1991 and in use since the late 1990s, it is used for hypertension and to reduce cardiovascular risk. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It has the longest half-life of the sartans, about 24 hours, and also partially activates PPAR-gamma, the same receptor targeted by the glitazones used in diabetes.

TelmisartanGo to the active ingredient →
TelmisartanActive ingredientTelmisartanCat. No. P-T040-001CAS 144701-48-4
Telmisartan-d3Isotopically labelledTelmisartan-d3Cat. No. P-T040-012CAS 1189889-44-8
Telmisartan-D7Isotopically labelledTelmisartan-D7Cat. No. P-T040-013CAS 1794754-60-1

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.